- Home
- NSTS vs PSTV Comparison
NSTS vs PSTV Comparison
Compare NSTS & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSTS
- PSTV
- Stock Information
- Founded
- NSTS 1921
- PSTV 1996
- Country
- NSTS United States
- PSTV United States
- Employees
- NSTS N/A
- PSTV N/A
- Industry
- NSTS Savings Institutions
- PSTV Medical/Dental Instruments
- Sector
- NSTS Finance
- PSTV Health Care
- Exchange
- NSTS Nasdaq
- PSTV Nasdaq
- Market Cap
- NSTS 58.7M
- PSTV 61.1M
- IPO Year
- NSTS N/A
- PSTV N/A
- Fundamental
- Price
- NSTS $11.00
- PSTV $0.54
- Analyst Decision
- NSTS
- PSTV Strong Buy
- Analyst Count
- NSTS 0
- PSTV 4
- Target Price
- NSTS N/A
- PSTV $7.75
- AVG Volume (30 Days)
- NSTS 5.1K
- PSTV 8.0M
- Earning Date
- NSTS 11-14-2025
- PSTV 10-30-2025
- Dividend Yield
- NSTS N/A
- PSTV N/A
- EPS Growth
- NSTS N/A
- PSTV N/A
- EPS
- NSTS N/A
- PSTV N/A
- Revenue
- NSTS $9,435,000.00
- PSTV $5,258,000.00
- Revenue This Year
- NSTS N/A
- PSTV $9.91
- Revenue Next Year
- NSTS N/A
- PSTV $1.06
- P/E Ratio
- NSTS N/A
- PSTV N/A
- Revenue Growth
- NSTS 69.39
- PSTV N/A
- 52 Week Low
- NSTS $10.72
- PSTV $0.16
- 52 Week High
- NSTS $13.32
- PSTV $2.31
- Technical
- Relative Strength Index (RSI)
- NSTS 41.39
- PSTV 44.71
- Support Level
- NSTS $11.00
- PSTV $0.49
- Resistance Level
- NSTS $11.26
- PSTV $0.58
- Average True Range (ATR)
- NSTS 0.14
- PSTV 0.05
- MACD
- NSTS 0.03
- PSTV -0.01
- Stochastic Oscillator
- NSTS 46.96
- PSTV 23.07
About NSTS NSTS Bancorp Inc.
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in market area of Lake County, Illinois and adjacent communities.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).